Forecasting the global burden of Alzheimer's disease

By R. Brookmeyer, Elizabeth K. Johnson, Kathryn Ziegler-Graham, H. M. Arrighi. Alzheimer's & Dementia, 2007

3,454 citations recorded by the source corpus.

Subfields: Aging, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/dbea787f86de850c11c02759fbeab2eaa408cf56

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Aging

Luigi Ferrucci

In Physiology

In Psychiatry and Mental health

Citations in the corpus

Brain MRI analysis for Alzheimer’s disease diagnosis using an ensemble system of deep convolutional neural networks (2018, background): “64 Billion people will be diagnosed with AD [1].”
Multi-Modal Multi-Task Learning for Joint Prediction of Multiple Regression and Classification Variables in Alzheimer’s Disease (2011, background): “6 million AD sufferers worldwide, and 1 in 85 people will be affected by 2050 (Ron et al., 2007).”
Computerized Cognitive Training with Older Adults: A Systematic Review (2012, background): “This expanding aging population highlights the need to identify quick, effective, low-cost solutions to delay pathological cognitive decline associated with aging [2].”
Amyloid Precursor Protein Processing and Alzheimer’s Disease (2011, background): “AD currently afflicts 26 million people worldwide with projections of a fourfold increase in that number by 2050 (Brookmeyer et al. 2007).”
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 (2022, positive): “20 This Article aims firstly to improve and expand on previous forecasting estimates by incorporating the estimated effect of future changes in selected modifiable risk factors and projecting dementia prevalence until 2050 globally, as well as by world region and country, and secondly to decompose…”
Therapeutics of Alzheimer's disease: Past, present and future. (2014, background): “One person for every 85 individuals can be expected to suffer from AD by the year 2050 (Brookmeyer et al., 2007).”
Diagnosis of Alzheimer's disease from EEG signals: where are we standing? (2010, background): “Diagnosis of MCI and AD is important for several reasons [4, 5, 6, 7, 8]:”
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (2010, neutral): “Consequently, early recognition of the disease needs to be improved; indeed, it is estimated that interventions that could delay the clinical onset of dementia by 1 year would reduce the prevalence in 2050 by 9 million case”
Identification of MCI Individuals Using Structural and Functional Connectivity Networks (2011, background): “It has been reported that the prevalence of AD is expected to quadruple by year 2050, where 1 in every 85 persons will be affected by the disease [3].”
Hearing Loss and Incident Dementia (2011, background): “Interventions that could merely delay the onset of dementia by 1 year would lead to a more than 10% decrease in the global prevalence of dementia in 2050.(3) Unfortunately, there are no known interventions that currently have such effectiveness.”